review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1081/CNV-120030216 |
P698 | PubMed publication ID | 15199610 |
P2093 | author name string | Charles Blanke | |
P2860 | cites work | Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma | Q73862914 |
Is the COX-2 effect on accelerated hematopoiesis mediated by prostaglandin E2? | Q74043281 | ||
Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells | Q74272756 | ||
Cyclooxygenase regulates angiogenesis induced by colon cancer cells | Q24336248 | ||
Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors | Q24648434 | ||
Arachidonic acid metabolism | Q28287622 | ||
Aspirin use and chronic diseases: a cohort study of the elderly | Q28341614 | ||
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2) | Q28586461 | ||
Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation | Q28622645 | ||
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis | Q29616121 | ||
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study | Q29620671 | ||
Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences | Q31111891 | ||
Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells | Q32139468 | ||
Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis | Q33180353 | ||
Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus | Q33806129 | ||
Risk of cardiovascular events associated with selective COX-2 inhibitors | Q34087109 | ||
Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. | Q34132261 | ||
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer | Q34277077 | ||
The role of cyclooxygenase-2 in prostate cancer | Q34335675 | ||
Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse | Q34418299 | ||
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis | Q34729756 | ||
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic | Q35163045 | ||
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. | Q35842152 | ||
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain | Q35953747 | ||
Mechanism of inhibition of tumour growth by aspirin and indomethacin | Q36042640 | ||
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential | Q36085224 | ||
Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing | Q36641159 | ||
Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer | Q36641883 | ||
Structure of the human cyclo-oxygenase-2 gene | Q36725123 | ||
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. | Q37366851 | ||
Targeting angiogenic processes by combination rofecoxib and ionizing radiation | Q39414041 | ||
Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis | Q39765865 | ||
Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines | Q40794085 | ||
The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells | Q40870787 | ||
Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention | Q40919512 | ||
Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture | Q41507875 | ||
Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract | Q41537389 | ||
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis | Q41709477 | ||
Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions | Q42094376 | ||
Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis | Q42255167 | ||
Immunohistochemical expression of cyclooxygenase-2 in skin cancers | Q42505683 | ||
Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac. | Q43557993 | ||
Prostaglandin E2 increases growth and motility of colorectal carcinoma cells | Q43559615 | ||
Platelet-derived growth factor stimulates phospholipase C-gamma 1, extracellular signal-regulated kinase, and arachidonic acid release in rat myometrial cells: contribution to cyclic 3',5'-adenosine monophosphate production and effect on cell prolif | Q43683552 | ||
Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor | Q43700532 | ||
Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells | Q43726282 | ||
Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity | Q43757544 | ||
The relationship between cyclooxygenase-2 expression and colorectal cancer. | Q44193470 | ||
Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse | Q45076575 | ||
Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. | Q52059420 | ||
Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm. | Q53395387 | ||
A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid. | Q53514245 | ||
Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. | Q54647090 | ||
Sulindac for polyposis of the colon. | Q54736921 | ||
A protective effect of sulindac against chemically-induced primary colonic tumours in mice. | Q54738047 | ||
Interleukin-1-Induced Prostaglandin E2 Biosynthesis in Human Synovial Cells Involves the Activation of Cytosolic Phospholipase A2 and Cyclooxygenase-2 | Q60321344 | ||
Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study | Q68123711 | ||
Effects of Long-term Sulindac Therapy on Colonic Polyposis | Q68263361 | ||
Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine | Q68723914 | ||
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 | Q70787131 | ||
PGE2 and angiogenesis | Q70898171 | ||
Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine | Q70958000 | ||
Phospholipid precursors of prostaglandins | Q72217755 | ||
Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases | Q73041199 | ||
Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer | Q73432823 | ||
Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas | Q73552652 | ||
P433 | issue | 2 | |
P304 | page(s) | 271-282 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Cancer Investigation | Q325953 |
P1476 | title | Role of COX-2 inhibitors in cancer therapy | |
P478 | volume | 22 |
Q37036925 | Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma |
Q39949862 | NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure. |
Q22299231 | Preadministration of High-Dose Salicylates, Suppressors of NF- B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy |
Q90401790 | Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition |
Q38944686 | The impact of COX-2 on invasion of osteosarcoma cell and its mechanism of regulation |
Search more.